Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Science to Business Program

Queen's University (Kingston, Ontario)

$30,000.00

Transition from Academia to the Technology Transfer Field

FY 2014-15

Summary
Bringing a new product to a state of use in the healthcare industry is the result of strong alliances between academia, pharma/biotechnology industry and a support from the government. Although Canadian scientific research in the healthcare field is internationally recognized for its excellence, many reports have identified a low performance in Canada in translating its academic innovations into applications. One of the reasons behind this paradox is the weakness of alliances connecting the different players of the Canadian healthcare industry. Building up those alliances requires a cadre of technology transfer decision makers knowledgeable in both health research and business management. As a scientist, my next professional goal is to acquire a strong understanding of the economic environment of business, through pursuing a MBA training, before my transition into the technology transfer field. As a future business trained-scientist, my long-term goal is to promote the commercialization of the innovations generated in academia, in Canada.
Program
Science to Business Program
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
325373
Name
Boudil Amine
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Science to Business
Projecttitle
Transition from Academia to the Technology Transfer Field
Programtype2
Studentship Programs
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$30,000
Cihrequipment2
$0
Programname2
Science to Business Program
Keyworddelim
Business-Trained Scientists; Scientific Research In Academia; Technical Knowledge In Business Management; Technology Transfer In Healthcare Industry
Abstract
Bringing a new product to a state of use in the healthcare industry is the result of strong alliances between academia, pharma/biotechnology industry and a support from the government. Although Canadian scientific research in the healthcare field is internationally recognized for its excellence, many reports have identified a low performance in Canada in translating its academic innovations into applications. One of the reasons behind this paradox is the weakness of alliances connecting the different players of the Canadian healthcare industry. Building up those alliances requires a cadre of technology transfer decision makers knowledgeable in both health research and business management. As a scientist, my next professional goal is to acquire a strong understanding of the economic environment of business, through pursuing a MBA training, before my transition into the technology transfer field. As a future business trained-scientist, my long-term goal is to promote the commercialization of the innovations generated in academia, in Canada.
Competitiondate
201502
Approvedterm2
1 yr 0 mth
Pinamesdelim
Boudil, Amine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $30,000~ $0~
Queen's University (Kingston, Ontario) - $30,000 Gran… | Canada Spends